Skip to main content
2026 ACVIM Forum Main banner
Icon Legend
This session is not on your agenda.
This session is on your agenda. Click again to remove it.
Presentation Icons
ACVIM Resident Research Award Eligible
ACVIM Resident Research Award Eligible
Additional Fees May Be Required
Additional Fees May Be Required
By Invite Only
By Invite Only
Capturing for On Demand
Capturing for On Demand
Cardiology Research Abstract Award Eligible
Cardiology Research Abstract Award Eligible
ERC Approved Lecture for ACVIM Residency
ERC Approved Lecture for ACVIM Residency
Poster
Poster
Livestream
Livestream
One Health
One Health
Pre-Registration Required
Pre-Registration Required
Research Abstract
Research Abstract
Specialty Symposium
Specialty Symposium
ACVIM Resident Research Award Winner
ACVIM Resident Research Award Winner
Cardiology Research Abstract Award Winner
Cardiology Research Abstract Award Winner

Andi Flory, DVM, DACVIM (Oncology), MBA (she/her/hers)

Head of Medical Oncology Strategy and Portfolio Support, Global Medical Affairs
Zoetis
Encinitas, California, United States

Dr. Andi Flory is board-certified in Medical Oncology. She underwent training at Ohio State and Cornell University, and has worked as a medical oncologist in the US and Australia. Andi co-founded and served as Chief Medical Officer at PetDx for 5 years, which brought liquid biopsy to veterinary medicine, and under which she published many studies demonstrating the benefits of blood-based cancer detection. Dr. Flory is widely published in the veterinary literature and has recently joined Zoetis as Head of Medical Oncology Strategy and Portfolio Support. In addition to noninvasive cancer detection and cancer genomics, she has special interests in novel therapies for lymphoma, cancer immunotherapy, primary care-specialist collaboration, and cancer-related quality of life.

Disclosure(s): Zoetis: Employed by and shareholder in Zoetis (Ongoing), Speaker for and employed by Zoetis (Ongoing)

Presentation(s):